Concepedia

M. Bernhart

MB

Statistics

Publications

5

Citations

117

H-Index

5

Active since

1992

Affiliations

Krankenhaus der Elisabethinen(Current)

Ludwig Boltzmann Institute for Cancer Research

University Hospital Innsbruck

Vienna General Hospital

Hanusch Hospital

M. Bernhart is an author at Krankenhaus der Elisabethinen specializing in interferon-based therapy, hematology, and pharmacotherapy.

Publications per year

1992–2003

5

Publications

5

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma

H. Kaufmann, Elisabeth Krömer, Thomas Nösslinger et al. · European Journal Of Haematology · 2003 · 36 citations · Full text

, , +17

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: Results of the austrian multicenter phase II study

Josef Thaler, Wolfgang Hilbe, Ute Apfelbeck et al. · Leukemia Research · 1997 · 31 citations

, , +4

Remission may continue after termination of rIFNα ‐2b treatment for essential thrombocythemia

H. Kasparu, M. Bernhart, O. Krieger et al. · European Journal Of Haematology · 1992 · 22 citations

, , +10

Interferon-α for the treatment of elderly patients with chronic myeloid leukaemia

Wolfgang Hilbe, Ute Apfelbeck, Michael Fridrik et al. · Leukemia Research · 1998 · 17 citations

, , +9

A short multilingual quality of life questionnaire ? practicability, reliability and interlingual homogeneity

Heinz T�chler, Sven Hofmann, M. Bernhart et al. · Quality of Life Research · 1992 · 11 citations

, , +16

1–5 of 5